The current status of infertility associated with pelvic endometriosis.
D000858:Anovulation / Q000209:etiology; D003131:Combined Modality Therapy; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use; D003338:Corpus Luteum / Q000503:physiopathology; D003613:Danazol / Q000627:therapeutic use; D004715:Endometriosis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D007247:Infertility, Female / Q000209:etiology* / Q000628:therapy; D008598:Menstruation; D008777:Methyltestosterone / Q000627:therapeutic use; D010386:Pelvic Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D011247:Pregnancy; D011453:Prostaglandins / Q000378:metabolism
D003277:Contraceptives, Oral, Combined; D004967:Estrogens; D006728:Hormones; D011453:Prostaglandins; D007987:Gonadotropin-Releasing Hormone; C010661:surfagon; D003613:Danazol; D008777:Methyltestosterone